US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

268.15

-3.0800-1.14%

Post-market: 268.150.00000.00%19:30 EDT

Volume:23.51K

Turnover:6.32M

Market Cap:2.91B

PE:31.38

High:271.63

Open:271.63

Low:267.73

Close:271.23

52wk High:274.99

52wk Low:173.98

Shares:10.85M

Float Shares:10.85M

Volume Ratio:0.78

T/O Rate:0.22%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.04

PE(LYR):7.10

Loading ...

Overview Company News Filings

Bruker announces strategic collaboration with Atinary Technologies

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

THOMSON REUTERS

Bruker Corporation - Makes Minority Investment in Atinary; Financial Details not Disclosed

THOMSON REUTERS

Bruker (BRKR) Could Be 6% Undervalued After Quarterly Loss And 2026 Guidance

Simply Wall St.

Bruker Takes Majority Stake in Organ-on-a-Chip Developer Mimetas

Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development

THOMSON REUTERS

Bruker Corporation - Financial Details not Disclosed; Mimetas to Operate Under Existing Brand and Management

THOMSON REUTERS

Bruker Corporation - Mimetas Provides Scalable Organ-on-a-Chip Solutions for Human-Relevant Tissues

THOMSON REUTERS

NEO Battery Amends $4 Million LIFE Offering to Fund South Korea Expansion

Grail announces FDA advisory committee meeting to review Galleri test PMA

De Dietrich Joins PIPAC Consortium to Develop Continuous API Manufacturing Platform

Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline

NeoGenomics Chief Accounting Officer Greg D. Aunan Disposes of 20,000 Shares for $321,400

The Race to Come up with the Next Big Sleep Drug

Corcept Therapeutics (CORT) Stock Could Be Undervalued Despite Mixed Broader Checks

Simply Wall St.

Deltic Energy sets remote court hearing as NEO NEXT+ cash takeover nears completion

Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference

How NeoGenomics’ Q2 Profit Return And Higher 2026 Outlook At NeoGenomics (NEO) Has Changed Its Investment Story

Simply Wall St.

Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40

Wall Street Analysts Are Bullish on Top Healthcare Picks

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/FBT/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":268.15,"timestamp":1789761600000,"preClose":271.23,"halted":0,"volume":23507,"hourTrading":{"tag":"盘后","latestPrice":268.15,"preClose":268.15,"latestTime":"19:30 EDT","volume":17,"amount":4553.29,"timestamp":1789774206683,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.011355675994543526,"floatShares":10850002,"shares":10850002,"eps":8.545272,"marketStatus":"Market Closed","change":-3.08,"latestTime":"09-18 16:00:00 EDT","open":271.63,"high":271.63,"low":267.73,"amount":6319864.942380001,"amplitude":0.014379,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":271.23,"sharesOutstanding":11450002,"nav":270.95,"aum":2953355541.9,"bidAskSpread":0.00095,"preHourTrading":{"tag":"盘前","latestPrice":271.23,"preClose":271.23,"latestTime":"07:36 EDT","volume":4,"amount":1084.9316,"timestamp":1789731363239,"change":0,"changeRate":0,"amplitude":0.000043},"postHourTrading":{"tag":"盘后","latestPrice":268.15,"preClose":268.15,"latestTime":"19:30 EDT","volume":17,"amount":4553.29,"timestamp":1789774206683,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7794563330839,"impliedVol":0.2045,"impliedVolPercentile":0.4223},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10850002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":0.7794563330839,"shares":10850002,"dividePrice":0,"high":271.63,"amplitude":0.014379,"preClose":271.23,"low":267.73,"week52Low":173.975,"pbRate":"1.04","psRate":"701.87","week52High":274.99,"institutionHeld":0,"latestPrice":268.15,"eps":8.545272,"divideRate":0,"volume":23507,"delay":0,"ttmEps":8.545272,"open":271.63,"prevYearClose":206.52,"prevWeekClose":261.85,"prevMonthClose":267.15,"prevQuarterClose":247.89,"fiveDayClose":261.85,"twentyDayClose":268.125,"sixtyDayClose":237.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658252992","title":"Bruker announces strategic collaboration with Atinary Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2658252992","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658252992?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:15","pubTimestamp":1786446917,"startTime":"0","endTime":"0","summary":"Bruker (BRKR) Corporation announced an expanded strategic collaboration with Atinary Technologies. Financial details were not disclosed. Atinary in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bruker-announces-strategic-collaboration-with-atinary-technologies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bruker-announces-strategic-collaboration-with-atinary-technologies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","LU0757428866.USD","BRKR","TINY","LU1815336091.USD","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658418994","title":"Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories","url":"https://stock-news.laohu8.com/highlight/detail?id=2658418994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658418994?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA70R2HL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0757428866.USD","BRKR","TINY","LU1815336091.USD","FBT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658099446","title":"Bruker Corporation - Makes Minority Investment in Atinary; Financial Details not Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2658099446","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658099446?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA70R2HL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","FBT","TINY","LU1815336091.USD","LU0757428866.USD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658011961","title":"Bruker (BRKR) Could Be 6% Undervalued After Quarterly Loss And 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2658011961","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658011961?lang=en_us&edition=fundamental","pubTime":"2026-08-11 11:31","pubTimestamp":1786419097,"startTime":"0","endTime":"0","summary":"Why Bruker stock is back in focus after the latest quarterly update\nBruker (BRKR) is back on investors’ radar after second quarter results combined rising sales with a reported net loss driven largely by impairment charges. Fresh 2026 revenue guidance added another key data point for the stock.\nSee our latest analysis for Bruker.\nBruker’s latest guidance for 2026, combined with the second quarter impairment charges, has come alongside a 25.91% 90 day share price return and an 83.88% 1 year...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/bruker-brkr-could-be-6-undervalued-after-quarterly-loss-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/bruker-brkr-could-be-6-undervalued-after-quarterly-loss-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1815336091.USD","BRKR","BK4121","LU0757428866.USD","TINY","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658383189","title":"Bruker Takes Majority Stake in Organ-on-a-Chip Developer Mimetas","url":"https://stock-news.laohu8.com/highlight/detail?id=2658383189","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658383189?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:01","pubTimestamp":1786359686,"startTime":"0","endTime":"0","summary":"Bruker takes majority stake in organ-on-a-chip developer MIMETASBruker took a majority stake in MIMETAS, expanding into organ-on-a-chip microphysiological systems for drug discovery and preclinical te","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL7NsKX1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRKR","LU1815336091.USD","TINY","BK4121","LU0757428866.USD","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980054","title":"Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980054?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA49P62Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","TINY","BK4121","LU0757428866.USD","LU1815336091.USD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938953","title":"Bruker Corporation - Financial Details not Disclosed; Mimetas to Operate Under Existing Brand and Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938953?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA49P62Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","TINY","LU0757428866.USD","FBT","LU1815336091.USD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658389549","title":"Bruker Corporation - Mimetas Provides Scalable Organ-on-a-Chip Solutions for Human-Relevant Tissues","url":"https://stock-news.laohu8.com/highlight/detail?id=2658389549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658389549?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA49P62Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0757428866.USD","BK4121","LU1815336091.USD","TINY","BRKR","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657621846","title":"NEO Battery Amends $4 Million LIFE Offering to Fund South Korea Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657621846","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657621846?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:41","pubTimestamp":1786138895,"startTime":"0","endTime":"0","summary":"NEO Battery Materials Ltd ( ($TSE:NBM) ) just unveiled an announcement. NEO Battery Materials Ltd. has amended the terms of its non-brokered LIFE O...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neo-battery-amends-4-million-life-offering-to-fund-south-korea-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neo-battery-amends-4-million-life-offering-to-fund-south-korea-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LIFE","NEO","FBT","BK4139","UYM","BK4563","LU0012050646.USD","BK4173","BK4121","BK4196","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642727","title":"Grail announces FDA advisory committee meeting to review Galleri test PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642727","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642727?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115445,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","FBT","BK4129","LABU","SBIO","PBE","PMA","BK4588","IBRN","BK4585","XBIX","GRAL","BK4139","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657697686","title":"De Dietrich Joins PIPAC Consortium to Develop Continuous API Manufacturing Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2657697686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657697686?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:51","pubTimestamp":1786085493,"startTime":"0","endTime":"0","summary":"De Dietrich joins PIPAC consortium to develop continuous API manufacturing platformDe Dietrich joined the PIPAC consortium with Alysophil, Bruker, Novalix to validate a continuous API manufacturing pl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL7SFgXp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","BK4121","LU1815336091.USD","BRKR","LU0757428866.USD","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657369495","title":"Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657369495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657369495?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:11","pubTimestamp":1786083103,"startTime":"0","endTime":"0","summary":"An update from Oxford BioMedica ( ($GB:OXB) ) is now available. Oxford Biomedica, a specialist cell and gene therapy CDMO, reported around 9% reven...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oxford-biomedica-trims-2026-outlook-but-leans-on-record-client-wins-and-growing-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oxford-biomedica-trims-2026-outlook-but-leans-on-record-client-wins-and-growing-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IBBQ","TBXU","OXM","SYNB","HELX","CNCR","GNOM","WDNA","IBB","IDNA","BK4202","FBT","LFSC","JDOC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520326","title":"NeoGenomics Chief Accounting Officer Greg D. Aunan Disposes of 20,000 Shares for $321,400","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520326","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520326?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:03","pubTimestamp":1786046585,"startTime":"0","endTime":"0","summary":"NeoGenomics Chief Accounting Officer Greg D. Aunan disposes of 20,000 shares for $321,400NeoGenomics Chief Accounting Officer Greg D. Aunan sold 20,000 common shares on Aug. 4 at USD 16.07.Directly he","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL64M2fb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NeoGenomics Chief Accounting Officer Greg D. Aunan Disposes of 20,000 Shares for $321,400","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4196","LU0106261612.USD","LU0012050646.USD","NEO","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657651052","title":"The Race to Come up with the Next Big Sleep Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2657651052","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657651052?lang=en_us&edition=fundamental","pubTime":"2026-08-07 02:30","pubTimestamp":1786041000,"startTime":"0","endTime":"0","summary":"Narcolepsy isn't easy to treat. Existing drugs manage patients' symptoms -- notably excessive daytime sleepiness and difficulty sleeping at night -- rather than the cause. Yet a new type of drug is em","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0323591593.USD","LU0354030438.USD","LU1623119135.USD","IE0005OL40V9.USD","TMED","TRUH","LU0385154629.USD","IE00BJT1NW94.SGD","LU2089284900.SGD","LU2237443895.HKD","LU0820561818.USD","GB00BDT5M118.USD","LU0256863902.USD","BK4007","IE0009355771.USD","LU1720051108.HKD","SGXZ51526630.SGD","LLII","SG9999015978.USD","LU0353189763.USD","LU1291159041.SGD","LU1548497426.USD","SG9999018857.SGD","LU0289739699.SGD","IE00B1BXHZ80.USD","LU0225283273.USD","SG9999018865.SGD","SGXZ31699556.SGD","LU2023250330.USD","SG9999014906.USD","LU2746668974.SGD","LU1366192091.USD","LU0114720955.EUR","LU1551013342.USD","IE0001KFT4U8.USD","LU1988902786.USD","OZEM","LU0672654240.SGD","LU0345770993.USD","IE00BK4W5M84.HKD","IHE","LU2361044949.HKD","LU1064131342.USD","LLYX","ILDR","LU1093756168.USD","LU1093756325.SGD","LU2750360641.GBP","FBT","LU1720051017.SGD","LU0106261372.USD","ELIS","IYH","LU2112291526.USD","LU2265009873.SGD","LU0882574055.USD","LU0256863811.USD","SG9999015952.SGD","FHLC","LU2471134796.USD","LU0061475181.USD","IE00BN29S564.USD","LU2264538146.SGD","LU1057294990.SGD","LU2896262040.SGD","LU0158827948.USD","WDNA","IE00BFSS7M15.SGD","LU0174119429.USD","LU2028103732.USD","LU1868837136.USD","ALKS","LU0320765992.SGD","LU0094547139.USD","LU1035775433.USD","LU2089283258.USD","HRTS","LU1974910355.USD","LU0079474960.USD","LU2237443382.USD","LU0683600562.USD","BK4581","MHIP","IE0004445239.USD","LU0787776722.HKD","LU2462157665.USD","LU1145028129.USD","LU2271345857.HKD","LU2361044865.SGD","LU0964807845.USD","SG9999017495.SGD","BK4534","GDOC","LU0471298694.HKD","LU0122379950.USD","LU0133085943.USD","LU2237443622.USD","LU2750360997.AUD","PJP","SGXZ99366536.SGD","BK4585","LU2168563687.JPY","BK4588","LU0882574139.USD","LU0345770308.USD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU0109391861.USD","LU0820561909.HKD","LU2491050154.USD","PSIL","SGXZ81514606.USD","LU2168564065.EUR","VHT","LU0820562030.AUD","LU2491050071.SGD","LU2089984988.USD","IE00BJJMRX11.SGD","LU2237443465.HKD","SGXZ57979304.SGD","SG9999014914.USD","LU0417517546.SGD","IE00B1XK9C88.USD","LU0210536198.USD","LU2361045086.USD","LU2023250504.SGD","LU2237438978.USD","LU2468319806.SGD","CANC","IE00BK4W5L77.USD","LU1989771016.USD","LU0097036916.USD","LU1917777945.USD","LU0320765059.SGD","PSCH","LU1061106388.HKD","SG9999014898.SGD","BK4599","LU1280957306.USD","LU2237443549.SGD","IE00B7KXQ091.USD","LU0456855351.SGD","IE00BFTCPJ56.SGD","IE00B775H168.HKD","LU2324357040.USD","LU0823416689.USD","LU2471134879.HKD","LU2417539215.USD","LU2471134523.USD","LU2552382215.SGD","LU0823434583.USD","MEDX","LU0158827781.USD","LU0234572021.USD","LU0266013472.USD","LU2023251221.USD","SG9999001176.USD","IE00BKPKM429.USD","TAK","LU1127390331.HKD","LU0708995401.HKD","LU2471134952.CNY","IE0004445015.USD","LU1804176565.USD","LU0786609619.USD","LU2213496289.HKD","LU2456880835.USD","LU2111349929.HKD","LU2552382058.USD","IE00BJJMRY28.SGD","JDOC","LU0006306889.USD","LU1023059063.AUD","LU1232071149.USD","LU1868836757.USD","LU2063271972.USD","LU2236285917.USD","LU2552382132.HKD","LU0689472784.USD","LU2168564222.USD","PPH","FTXH","IXJ","SG9999013999.USD","LU0823434740.USD","IE00BKDWB100.SGD","LU1868836591.USD","LU1069344957.HKD","IE00B4JS1V06.HKD","SG9999014880.SGD","LU0203201768.USD","SG9999001176.SGD","BK4139","IBRN","SG9999015986.USD","LU0640476718.USD","LU0471298777.SGD","LU2168564149.EUR","SG9999015945.SGD","LU1979441026.SGD","ELIL","AGNG","LU1868837300.USD","LU1323610961.USD","LU2461242641.AUD","LU1712237335.SGD","LU0109394709.USD","LU2106854487.HKD","IE0002141913.USD","LU0058720904.USD","LU2491049909.HKD","LU1267930730.SGD","LU1983299246.USD","LU2168564495.EUR","LU2756315318.SGD","THNR","LU0198837287.USD","BK4533","LU1868836914.USD","LU2357305700.SGD","LU1629891620.HKD","LLY","CURE","LU2746668461.USD","MEDI","IE00BWXC8680.SGD","LU2108987350.USD","IE00B2B36J28.USD","LU2237443978.SGD","XLV","LU2756315664.SGD","LU0316494557.USD","LU0353189680.USD","LU0238689110.USD","LU0203202063.USD","LU0889565916.HKD","LU1814569148.SGD","LU0466842654.USD","LU2087625088.SGD","LU2462591350.SGD","LU0432979614.USD","LU2602419157.SGD","LU1551013425.SGD","LU0943347566.SGD","LU0354030511.USD","IE00BJLML261.HKD","BK4516","IE00BFSS8Q28.SGD","LLYZ","LU2211815571.USD","IE00B4R5TH58.HKD","RXL","LU2360106947.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656597","title":"Corcept Therapeutics (CORT) Stock Could Be Undervalued Despite Mixed Broader Checks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656597","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656597?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:39","pubTimestamp":1786030757,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics stock has delivered a very large 5 year return, yet its recent valuation checks suggest the shares are not an obvious bargain at today's level.\n\nOver the past 5 years, Corcept Therapeutics has returned about 4.4x, which sets a high bar for any further upside to be justified by fundamentals.\nInvestor focus is currently on how demand for the company’s treatments and late stage pipeline can support future revenue, while execution and clinical outcomes across those programs...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-stock-could-be-undervalued-despite","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-stock-could-be-undervalued-despite","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4532","LU0566484027.USD","PSCH","CORT","LU1559883803.SGD","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657020325","title":"Deltic Energy sets remote court hearing as NEO NEXT+ cash takeover nears completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657020325","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657020325?lang=en_us&edition=fundamental","pubTime":"2026-08-06 14:12","pubTimestamp":1785996756,"startTime":"0","endTime":"0","summary":"Deltic Energy ( ($GB:DELT) ) has shared an announcement. Deltic Energy and NEO NEXT+ Energy Upstream UK have confirmed progress on NEO NEXT+’s reco...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/deltic-energy-sets-remote-court-hearing-as-neo-next-cash-takeover-nears-completion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/deltic-energy-sets-remote-court-hearing-as-neo-next-cash-takeover-nears-completion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0106261612.USD","LU0012050646.USD","BK4144","NEO","BK4196","BESF","BK4121","NEXT","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657023575","title":"Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2657023575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657023575?lang=en_us&edition=fundamental","pubTime":"2026-08-06 13:45","pubTimestamp":1785995139,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) has shared an announcement. Circio Holding ASA, a biotechnology company specializing in circular RNA expression systems...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circios-circvec-gene-therapy-platform-secures-oral-slot-at-top-european-esgct-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circios-circvec-gene-therapy-platform-secures-oral-slot-at-top-european-esgct-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","XT","BBP","JDOC","TBXU","EPV","BK4588","RNA","GNOM","CNCR","SYNB","IBB","LNGR","IEIH","RSPH","IBBQ","FHLC","AGNG","BK4139","DARP","FBT","IE0009354923.USD","FWD","BK4585","LFSC","RDMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657509379","title":"How NeoGenomics’ Q2 Profit Return And Higher 2026 Outlook At NeoGenomics (NEO) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2657509379","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657509379?lang=en_us&edition=fundamental","pubTime":"2026-08-06 11:41","pubTimestamp":1785987715,"startTime":"0","endTime":"0","summary":"In late July 2026, NeoGenomics reported second-quarter 2026 results showing sales of US$201.66 million and a return to profitability with net income of US$2.24 million, alongside higher first-half revenue and a sharply reduced year-to-date net loss.\nThe company also raised its full-year 2026 revenue outlook to US$802 million–US$806 million and tightened its projected net loss range, which points to improving operating performance and greater confidence in its business trajectory.\nNext, we’ll...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-neogenomics-q2-profit-return-and-higher-2026-outlook-at","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-neogenomics-q2-profit-return-and-higher-2026-outlook-at","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","LU0012050646.USD","NEO","FBT","LU0106261612.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657571260","title":"Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2657571260","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657571260?lang=en_us&edition=fundamental","pubTime":"2026-08-06 06:11","pubTimestamp":1785967865,"startTime":"0","endTime":"0","summary":"Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon disposes of 1,540 common shares worth $175,806.40Corcept Therapeutics Chief Accounting & Technology Officer Joseph Douglas Lyon sold 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL4ffvrh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","CORT","FBT","LU1559883803.SGD","BK4007","LU0566484027.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657256541","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657256541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657256541?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:01","pubTimestamp":1785931309,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IDEAYA Biosciences (IDYA), Bruker (BRKR) and Rhythm ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-277?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-277?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BRKR","TINY","IDYA","BK4121","LU0757428866.USD","LU1815336091.USD","FBT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}